Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Unknown × NET × Clear all

Phase

Phase 2 16 Phase NA 10 Phase 1/2 6 Phase 1 5 Phase EARLY_PHASE1 3 Phase 4 1 Phase 3 1 Phase 2/3 1

Status

Completed 7 Recruiting 4 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 115 Breast 57 Lymphoid 48 Other hematologic neoplasm 40 Thoracic 36 Genitourinary 27 Tumor-Agnostic 18 Head & Neck 18 Dermatologic 16 Gynecologic 14 Classical hematology 13 Myeloid 8 CNS 8 Plasma cell 6 Other 6 Endocrine 6 Sarcoma 3 Other solid neoplasm 3 NET 1

Conditions

Neuroendocrine Tumors 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03083210 2019-05-20

Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET

Samsung Medical Center

Phase 4 Unknown

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡